| Literature DB >> 31886180 |
Xinjie Wu1,2, Wei Sun1,2, Mingsheng Tan2.
Abstract
BACKGROUND: The present study aims to investigate the incidence and risk factors associated with postoperative delirium in patients undergoing spine surgery.Entities:
Mesh:
Year: 2019 PMID: 31886180 PMCID: PMC6899276 DOI: 10.1155/2019/2139834
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Flow chart of the literature search and article selection.
Study characteristics and quality assessment.
| Author | Publication year | Country | Study type | Sample size | Age mean (SD, range) years | Sex ratio (M : F) | Patients who underwent surgery | Delirium diagnosis tool | Delirium incidence | Duration of delirium (days) | Significant factors | Study quality |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pan et al. [ | 2019 | Korea | Prospective | 83 | 71.4 ± 4.6 | 27 : 56 | Lumbar spine | CAM | 12/83 (14.5%) | 2.6 (1–5) | Male, parkinsonism, lower baseline MMSE score | 8 |
| Oe et al. [ | 2019 | Japan | Retrospective | 319 | >18 | 85 : 234 | Spinal deformity | — | 30/319 (9.4%) | — | Age, PNI | 7 |
| Elsamadicy et al. [ | 2019 | USA | Retrospective | 138 | ≥18 | 40 : 98 | Complex spinal fusion (≥5 levels) | — | 15/138 (10.9%) | — | Age, intraoperative ketamine use | 7 |
| Takenaka et al. [ | 2019 | Japan | Prospective | 13188 | 11–94 | 7174 : 6014 | Lumbar spine | — | 65/13188 (0.49%) | — | CVD, dural tear | 8 |
| Kin et al. [ | 2019 | Japan | Retrospective | 67 | 69.6 ± 12.0 | 49 : 18 | Cervical spine | CAM, DSM-IV | 10/67 (14.9%) | <3 | Low general health perception | 8 |
| Oichi et al. [ | 2019 | Japan | Retrospective | 88370 | ≥65 | 47408 : 40962 | Lumbosacral, thoracic, cervical, unspecified | — | 4502/88370 (5.1%) | — | Age >80 | 8 |
| Watanabe et al. [ | 2019 | Japan | Retrospective | 322 | 75.7 years (67–89) | 69 : 253 | Thoracic, lumbar spine | — | 26/322 (8.1%) | — | Parkinsonism | 7 |
| Morino et al. [ | 2018 | Japan | Retrospective | 532 | 64.2 (10–89) | 283 : 249 | Spine | DSM-IV | 59/532 (11.1%) | <5 | Blood loss | 8 |
| Adogwa et al. [ | 2018 | USA | Retrospective | 82 | ≥65 | 33 : 49 | Thoracolumbar deformity | CAM | 22/82 (18%) | — | Cognitive impairment | 7 |
| Adogwa et al. [ | 2018 | USA | Retrospective | 293 | ≥18 | 105 : 188 | Lumbar spine | — | 28/293 (9.6%) | — | CKD | 7 |
| Susano et al. [ | 2018 | Portugal | Retrospective | 715 | 73.6 ± 6.0 | 351 : 400 | Cervical, lumbar spine | — | 127/715 (17.8%) | — | Age, ASA physical status ≥3, METs <4, depression, nonelective surgery, invasiveness tier 3 or 4, BIS monitoring, mean pain score postoperative day 1 | 7 |
| Elsamadicy et al. [ | 2018 | USA | Retrospective | 204 | ≥60 | 204 : 0 | Elective complex spinal fusion (≥3 levels) | — | 25/204 (12.3%) | — | Preoperative hgb level <13.5 g/dl | 7 |
| Oichi et al. [ | 2018 | Japan | Retrospective | 2712 | ≥20 | 1738 : 974 | Lumbar spine | — | 52/2712 (1.9%) | — | Open laminectomy | 7 |
| Kobayashi et al. [ | 2018 | Japan | Retrospective | 35 | 91.3 (90–98) | 14 : 21 | Cervical, thoracic, lumbar spine | — | 11/35 (31.43%) | — | — | 6 |
| Yoshida et al. [ | 2018 | Japan | Retrospective | 304 | 62.9 (18–84) | 64 : 240 | Spinal deformity | — | 34/304 (11.2%) | — | Age, operative time ≥6 hours | 8 |
| Kim et al. [ | 2018 | Korea | Prospective | 104 | 71.7 ± 4.7 | 36 : 68 | Cervical, thoracic, lumbar spine | CAM | 15/104 (14.4%) | — | Hyposmia (CCSIT score <9) and RBD (RBDSQ-K >4) | 8 |
| Ramos et al. [ | 2017 | USA | Retrospective | 11043 | 67 ± 9 | 2981 : 8062 | Spinal deformity | — | 269/11043 (2.4%) | — | Movement disorder, parkinsonism | 7 |
| Oichi et al. [ | 2017 | Japan | Retrospective | 6921 | ≥20 | 3324 : 3597 | Lumbosacral, thoracic, cervical, unspecified | — | 670/6921 (9.7%) | — | Parkinsonism | 7 |
| Elsamadicy et al. [ | 2017 | USA | Retrospective | 453 | ≥65 | 211 : 242 | Spine | DSM-V | 17/453 (3.75%) | — | Superficial surgical site infection, UTI, length of hospital stay | 8 |
| Elsamadicy et al. [ | 2017 | USA | Retrospective | 923 | ≥18 | 333 : 590 | Spinal deformity | — | 66/923 (7.15%) | — | Depression, age, operative time, postoperative UTI | 7 |
| Elsamadicy et al. [ | 2017 | USA | Retrospective | 839 | ≥18 | 329 : 510 | Elective complex spinal fusion (≥3 levels) | — | 67/839 (7.98%) | — | — | 6 |
| Radcliff et al. [ | 2017 | USA | Retrospective | 2792 | ≥65 | 1487 : 1305 | Cervical spine | — | 157/2792 (5.6%) | — | Dementia, TIA/stroke, age≥ 85 in cervical decompression patients | 7 |
| Jiang et al. [ | 2017 | China | Retrospective | 451 | 65.1 (45–84) | 226 : 225 | Cervical and lumbar spine | — | 42/451 (9.3%) | 6.7 (4–10) | Intraoperative hypotension <80 mmHg, intraoperative use of dezocine | 7 |
| Soh et al. [ | 2017 | Korea | Prospective | 109 | >70 | 56 : 53 | Cervical, thoracic, lumbar spine | ICDSC; CAM-ICU | 9/109 (8.2%) | — | Pulmonary disease | 7 |
| Adogwa et al. [ | 2017 | USA | Prospective e | 125 | ≥65 | 50 : 75 | Spinal deformity | — | 22/125 (17.6) | — | — | 7 |
| Adogwa et al. [ | 2017 | USA | Retrospective | 82 | ≥65 | 33 : 49 | Spinal deformity | — | 13/82 (15.9%) | — | Cognitive impairment | 7 |
| Kobayashi et al. [ | 2017 | Japan | Retrospective | 262 | 82.7 (80–91) | 142 : 140 | Cervical, thoracic, and lumbar spine | — | 15/262 (5.72) | <3 | Cervical lesion surgery, blood loss>300 mL | 7 |
| Brown et al. [ | 2016 | USA | Prospective | 195 | 74 (72–78) | 47 : 42 | Cervical, lumbar spine | CAM; CAM-ICU; DRS-98-R | 36/195 (18.5%) | — | Lower baseline MMSE score, higher average baseline pain, more intravenous fluid, baseline, antidepressant medication | 7 |
| Lee et al. [ | 2016 | Korea | Retrospective | 129 | 73.5 (70 to 85) | 51 : 78 | Lumbar spine | CAM; DSM-IV | 18/129 (13.9%) | 13.2 (1 to 92) | Cognitive impairment | 7 |
| Balabaud et al. [ | 2015 | France | Retrospective | 121 | 83.2 ± 2.4 | 48 : 73 | Lumbar spine | — | 16/(13%) | — | Instrumentation, blood loss | 7 |
| Glennie et al. [ | 2015 | Canada | Retrospective | 276 | 42.9 ± 18.8 | 190 : 86 | Thoracic, lumbar spine | — | 38/276 (13.8%) | — | Age, male, head injury | 7 |
| Dea et al. [ | 2014 | Canada | Prospective | 101 | 62 (33–85) | 50 : 51 | Thoracic, lumbar, sacral spine | — | 21/101 (20.8) | — | — | 6 |
| Seo et al. [ | 2014 | Korea | Prospective | 70 | 70.1 ± 5.8 | 32 : 38 | Cervical, lumbar spine | ICDSC; CAM-ICU | 17/70 (24.3%) | — | Preoperative GDS, BIS measured intraoperatively under 40 | 8 |
| Kelly et al. [ | 2014 | Canada | Prospective | 92 | 66.08 ± 10.59 | — | Lumbar spine | — | 5/92 (5.4%) | — | CCI, dural tear | 8 |
| Fineberg et al. [ | 2013 | USA | Retrospective | 578457 | >18 | 285520 : 292937 | Lumbar spine | — | 4857/578457 (0.84%) | — | Age ≥65, teaching hospital, alcohol abuse, deficiency anemia, congestive heart failure, coagulopathy, depression, DM with end-organ damage, drug abuse, hypertension, fluid/electrolyte disorders, metastatic neoplasm, neurological disorder, psychoses, pulmonary circulation disorders, renal failure, weight loss | 6 |
| Imagama et al. [ | 2011 | Japan | Retrospective | 918 | 54 (11–87) | 521 : 397 | Lumbar spine | — | 5/918 (0.54%) | — | — | 6 |
| Lee et al. [ | 2010 | Korea | Retrospective | 87 | 73.5 (70–85) | 27 : 50 | Lumbar spine | CAM, DSM-IV | 11/81 (13.6%) | 13.2 (1 to 92) | Cerebral vascular disease, low hemoglobin and hematocrit levels at 1 day after surgery, bad nutritional status | 7 |
| Ushida et al. [ | 2009 | Japan | Retrospective | 122 | 52–86 | — | Cervical spine | DOS, DSM-IV | 26/122 (21.3%) | — | Age >70, high-dose methylprednisolone (>1000 mg), hearing impairment | 6 |
| Gao et al. [ | 2008 | China | Retrospective | 549 | 48.2 (10–83) | 302 : 247 | Cervical, thoracic, lumbar, sacral spine | DOS, DSM-IV | 18/549 (3.3%) | 3.1 (1 to 8) | Central nervous system disorder, surgical history, age> 65, DM, blood transfusion ≥800 ml, hemoglobin <100 g/L | 7 |
| Kawaguchi et al. [ | 2006 | Japan | Retrospective | 341 | 59.2 (14–88) | 186 : 155 | Cervical, thoracic, lumbar, sacral spine | CAM, DSM–III–R | 13/341 (3.8%) | ≤7 | Low concentrations of hemoglobin and hematocrit 1 day after surgery, ambulatory status at admission | 8 |
DOS, delirium observation screening scale; DSM, diagnostic and statistical manual of mental disorders; CAM, confusion assessment method; MMSE, mini-mental state examination; CVD, cardiovascular disease; CKD, chronic kidney disease; CAM-ICU, confusion assessment method for the intensive care unit; DRS-98-R, delirium rating scale revised-98; ICDSC, intensive care delirium screening checklist; PNI, Prognostic Nutritional Index; ASA, American Society of Anesthesiologists physical status; BIS, Bispectral Index; METs, metabolic equivalents of task; UTI, urinary tract infection; RBD, rapid eye movement sleep behavior disorder; CCSIT, cross-cultural smell identification test; RBDSQ-K, Korean version of RBD screening questionnaire; TIA, transient ischemic attack; GDS, global deterioration scale; BIS, Bispectral Index; CCI, Charlson Comorbidity Index.
Figure 2Pooled result of incidence of delirium: (a) subgroup analysis based on the factor of country; (b) subgroup analysis based on the factor of study type; (c) subgroup analysis based on the factor of surgical site; (d) result of sensitive analysis; (e) Begg's funnel plot.
Outcomes of meta-analysis for risk factors.
| Risk factors | No. of studies | Pooled OR (95% CI) | Heterogeneity |
| Effects model |
|---|---|---|---|---|---|
| Admission to ICU | 3 | 2.51 (0.38–4.64) | 0 | 0.944 | Fixed |
| Age | 7 | 1.07 (1.04–1.09) | 16.5 | 0.304 | Fixed |
| Age >65 | 3 | 4.77 (4.37–5.16) | 0 | 0.383 | Fixed |
| Age >70 | 3 | 15.87 (6.03–41.73) | 48 | 0.14 | Fixed |
| Age >80 | 2 | 1.91 (1.78–2.03) | 0 | 0.844 | Fixed |
| Alcohol abuse | 4 | 2.11 (1.67–2.56) | 0 | 0.397 | Fixed |
| Anxiety | 2 | 1.74 (1.04–2.44) | 0 | 0.773 | Fixed |
| Blood loss | 5 | 1 (0.99–1.01) | 83.9 | <0.001 | Random |
| Blood transfusion | 3 | 0.62 (0.07–1.17) | 74.4 | 0.02 | Random |
| Cardiovascular comorbidity | 10 | 0.81 (0.34–1.29) | 0 | 0.697 | Fixed |
| CCI | 2 | 1.26 (0.56–1.96) | 0 | 0.355 | Fixed |
| Cervical surgery | 6 | 0.97 (0.45–1.48) | 0 | 0.514 | Fixed |
| Congestive heart failure | 3 | 1.4 (1.21–1.6) | 0 | 0.708 | Fixed |
| Depression | 7 | 2.5 (1.52–3.49) | 76 | <0.001 | Random |
| DM | 13 | 1.09 (0.6–1.59) | 0 | 0.978 | Fixed |
| Dural tear | 2 | 3.21 (0.07–6.35) | 0 | 0.864 | Fixed |
| Gender (male) | 17 | 0.81 (0.76–0.86) | 44.6 | 0.025 | Fixed |
| History of surgery | 6 | 1.09 (0.55–1.64) | 0 | 0.617 | Fixed |
| Hypertension | 13 | 1.12 (1.04–1.2) | 28.3 | 0.16 | Fixed |
| Kidney disease | 6 | 1.41 (1.16–1.66) | 0 | 0.92 | Fixed |
| MMSE score | 3 | 0.7 (0.5–0.89) | 51.7 | 0.126 | Random |
| Neurological disorder | 4 | 4.66 (4.22–5.11) | 0 | 0.521 | Fixed |
| Operated levels | 2 | 1.02 (0.81–1.22) | 0 | 0.523 | Fixed |
| Operation time | 4 | 1 (0.99–1) | 0 | 0.725 | Fixed |
| Parkinsonism | 5 | 5.37 (0.63–10.1) | 88 | <0.001 | Random |
| Preoperative VAS | 2 | 1.88 (1.11–2.64) | 0 | 0.816 | Fixed |
| Previous cerebral vascular diseases | 7 | 1.82 (0.7–2.94) | 0 | 0.952 | Fixed |
| Previous mild cognitive impairment | 5 | 2.43 (0.99–3.86) | 0 | 0.967 | Fixed |
| Previous opioid use | 3 | 1.86 (1.18–2.54) | 0 | 0.659 | Fixed |
| Psychoses | 5 | 2.77 (2.29–3.25) | 0 | 0.474 | Fixed |
| Pulmonary disease | 6 | 1.81 (1.27–2.35) | 0 | 0.925 | Fixed |
| Postoperative UTI | 2 | 5.68 (2.41–13.39) | 0 | 0.463 | Fixed |
| Superficial surgical site infection | 2 | 0.28 (-3.25-3.81) | 0 | 0.433 | Fixed |
CCI, Charlson Comorbidity Index; DM, diabetes mellitus; MMSE, mini-mental state examination; VAS, Visual Analogue Scale; UTI, urinary tract infection.
Figure 3Pooled result of male: (a) subgroup analysis based on the factor of study type; (b) Begg's funnel plot.
Figure 4Pooled result of cardiovascular comorbidity: (a) forest plot of cardiovascular comorbidity; (b) Begg's funnel plot.
Figure 5Pooled result of hypertension: (a) forest plot of hypertension; (b) Begg's funnel plot.
Figure 6Pooled result of parkinsonism: (a) forest plot of parkinsonism; (b) result of sensitive analysis.
Figure 7Pooled result of MMSE score. Subgroup analysis based on the factor of country.
Figure 8Pooled result of blood loss: (a) forest plot of blood loss; (b) result of sensitive analysis.
Figure 9Pooled result of blood transfusion: (a) forest plot of blood transfusion; (b) result of sensitive analysis.